Hematology

This review article explores key research highlights and new data on CLL presented at EHA 2025, considering how the latest clinical…

Since research on human gene therapy began, the expectations regarding its potential in treating haemophilia have been high. Haemophilia…

TEST In this feature, the authors critically analyse the European standards for Haemophilia Treatment Centres (HTC), examining their…

Rituximab, a monoclonal anti-CD20 antibody, has proven to be an excellent therapeutic agent for haematological diseases. Low-dose…

von Willebrand disease (VWD) is considered the most common inherited bleeding disorder, even surpassing haemophilia A. Nevertheless, VWD…

Synchronous twin malignancies, defined as the simultaneous occurrence of two distinct primary cancers in the same patient, represent a…

Topiramate is a well-known medication used for migraine and epilepsy. Bleeding is a rare and less documented side-effect of this treatment…

This year, the EHA Congress provided us with long-term follow-up of some very interesting study, including the GAIA/CLL13 trial…